Kaurene diterpene induces apoptosis in human leukemia cells partly through a caspase-8-dependent pathway

Masuo Kondoh1, Ikue Suzuki, Masao Sato

  • 1Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University, Machida, Tokyo, 194-8543, Japan. masuo@ac.shoyaku.ac.jp

Insights

Ent-11alpha-hydroxy-16-kauren-15-one (KD) induces apoptosis in leukemia cells by activating caspase-8. This compound shows promise as a cytotoxic agent, potentially overcoming drug resistance in cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Defects in apoptosis pathways drive cancer development and chemotherapy resistance.
  • Identifying agents that restore apoptosis in tumor cells is crucial for effective cancer treatment.

Purpose of the Study:

  • To investigate the mechanism of apoptosis induction by Ent-11alpha-hydroxy-16-kauren-15-one (KD) in human promyelocytic leukemia HL-60 cells.
  • To determine the role of caspase-8 in KD-induced apoptosis and its potential to overcome drug resistance.

Main Methods:

  • Treatment of HL-60 cells with KD.
  • Assessing apoptosis induction and caspase activation (caspase-8 and -9).
  • Utilizing caspase inhibitors and expressing catalytically inactive caspase-8.
  • Analyzing Bid cleavage and procaspase-8 processing.
  • Evaluating the effect of Bcl-2 overexpression on KD-induced cytotoxicity.

Main Results:

  • KD treatment activated both caspase-8 and -9.
  • A caspase-8 specific inhibitor, but not a caspase-9 inhibitor, attenuated KD-induced apoptosis.
  • KD induced time-dependent Bid cleavage and procaspase-8 processing, confirming caspase-8 dependency.
  • Overexpression of Bcl-2 did not confer resistance to KD, indicating its efficacy against drug-resistant factors.

Conclusions:

  • KD induces apoptosis in HL-60 cells via a caspase-8-dependent pathway.
  • KD demonstrates potential as a novel cytotoxic agent for overcoming cancer drug resistance.
  • Further research into KD could lead to new therapeutic strategies for chemoresistant cancers.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...